The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
暂无分享,去创建一个
G. Watkins | R. Mansel | W. Jiang | M. Al-Rawi | W. Jiang
[1] G. Watkins,et al. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. , 2004, European journal of cancer.
[2] W. Jiang,et al. Interleukin 7 induces the growth of breast cancer cells through a wortmannin‐sensitive pathway , 2004, The British journal of surgery.
[3] R. Mansel,et al. Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .
[4] R. Mansel,et al. Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells , 2003, Journal of cellular physiology.
[5] H. Kalthoff,et al. Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo , 2002, Langenbeck's Archives of Surgery.
[6] P. Hewett,et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. , 2002, Cancer research.
[7] W. Jiang,et al. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. , 2001, Biochemical and biophysical research communications.
[8] R. Dummer,et al. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. , 2001, Blood.
[9] G. R. Davies,et al. Interleukins 7 and 12 are expressed in head and neck squamous cancer. , 2001, Clinical otolaryngology and allied sciences.
[10] M. Karkkainen,et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. , 2001, Cancer research.
[11] M. Pepper,et al. Lymphangiogenesis and tumor metastasis: myth or reality? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] L. Orci,et al. Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.
[13] Seppo Ylä-Herttuala,et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.
[14] Thomas Hawighorst,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.
[15] Steven A. Stacker,et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.
[16] K. Aozasa,et al. Expression of Interleukin-7 and Its Receptor in Thyroid Lymphoma , 2000, Laboratory Investigation.
[17] Y. Maehara,et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues , 2000, British Journal of Cancer.
[18] K. Moelling,et al. Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.
[19] K. Matsumoto,et al. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] G. Oliver,et al. Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.
[21] J. Kurebayashi,et al. Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer , 1999, Japanese journal of cancer research : Gann.
[22] D. Whitcombe,et al. Detection of PCR products using self-probing amplicons and fluorescence , 1999, Nature Biotechnology.
[23] Takuma Sasaki,et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] D. Jackson,et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.
[25] E. Tschachler,et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.
[26] M. Mildner,et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[27] K. Alitalo,et al. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response , 1999, Oncogene.
[28] B. Seliger,et al. Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. , 1999, International journal of oncology.
[29] Vishva Dixit,et al. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.
[30] Yue,et al. Epithelial component of lymphoid stroma‐rich Warthin's tumour expresses interleukin (IL)‐7 , 1998, Histopathology.
[31] H. Kiyono,et al. Bacterial invasion induces interleukin‐7 receptor expression in colonic epithelial cell line, T84 , 1997, European journal of immunology.
[32] L. Zitvogel,et al. Interleukin‐7 (IL‐7) in Colorectal Cancer: IL‐7 is Produced by Tissues from Colorectal Cancer and Promotes Preferential Expansion of Tumour Infiltrating Lymphocytes , 1997, Scandinavian journal of immunology.
[33] L. Aiello,et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. , 1996, The Journal of clinical investigation.
[34] C. Soria,et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro , 1996, International journal of cancer.
[35] S. Dubinett,et al. Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[36] N. Iizuka,et al. Cytokine mRNA expression patterns in human esophageal cancer cell lines. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[37] I. Kerr,et al. Interleukin‐7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells , 1995, European journal of immunology.
[38] H. Ishii,et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. , 1995, The Journal of clinical investigation.
[39] C. Watson,et al. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. , 1995, British Journal of Cancer.
[40] H. Stein,et al. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease. , 1995, The American journal of pathology.
[41] H. Dadi,et al. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity. , 1994, Blood.
[42] T. Knobloch,et al. B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. , 1994, Journal of immunology.
[43] R. Whyte,et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.
[44] V. Diehl,et al. Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] P. Gruss,et al. Prox 1, a prospero-related homeobox gene expressed during mouse development , 1993, Mechanisms of Development.
[46] J. Frishman,et al. Genes for Interleukin 7 Are Transcribed in Leukemic Cell Subsets of Hdividuak with Chronic Lymphocytic Leukemia , 1993 .
[47] P. Leder,et al. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice , 1993, The Journal of experimental medicine.
[48] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[49] D. Kreutzer,et al. Cytokine expression by head and neck squamous cell carcinomas. , 1992, American journal of surgery.
[50] R. Strieter,et al. Interleukin-8. A corneal factor that induces neovascularization. , 1992, The American journal of pathology.
[51] P. Debré,et al. Interleukin-7 is a growth factor for Sézary lymphoma cells. , 1992, The Journal of clinical investigation.
[52] A. Ganser,et al. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. , 1992, Blood.
[53] H. Imura,et al. Co‐production of Interleukin‐1 and Interleukin‐6 in Tumor Cell Lines Elaborating Colony‐stimulating Factors , 1991, Japanese journal of cancer research : Gann.
[54] W. Digel,et al. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. , 1991, Blood.
[55] T. Agthoven,et al. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. , 1990, Blood.
[56] Masahiro Yamamoto,et al. Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas , 1989, FEBS letters.